Angina Is as Subjective as Any Other Pain

Almost 80% of all patients randomized in this study reported Canadian Cardiovascular Society class II or III angina, and almost all of them (97%) had more than 1 positive non-invasive ischemia test that matched the area of their single diseased coronary vessel. Beyond fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR), the study randomized patients to undergo angioplasty or a sham procedure (placebo group). We might have expected angioplasty patients to resolve their symptoms and placebo patients to continue with the same angina functional class. It should be noted that all patients were symptomatic and they all had single-vessel disease, with ischemia shown in more than one functional study.

Our expectations turned out to be quite different from reality, since almost half the patients who underwent angioplasty continued with angina and, more interestingly, 31.5% of placebo patients (i.e., those who underwent a sham procedure) reported being symptom-free. That is a significant difference, which leads us to conclude that, while angioplasty does actually improve symptoms, some things we are yet to understand.

 

Before randomization, all patients were assessed with iFR and FFR, while results were blinded. Mean FFR was 0.69 ± 0.16 and mean iFR was 0.76±0.22 (undoubtedly, all subjects were ischemic patients) in 196 study patients, among whom 103 underwent angioplasty and 93 underwent a placebo procedure.


Read also: CTO Revascularization Improves Quality of Life.


Angioplasty clearly improved stress echocardiography scores (p < 0.0001) and its effect was progressively more evident with decreasing FFR and iFR (p for interaction < 0.00001). That is the expectable, logical result for this study.

 

However, angioplasty did not improve angina frequency scores significantly more than placebo, and there was no detectable evidence of interaction with FFR (p = 0.849) or iFR (p = 0.783) results.


Read also: Manual vs. Mechanical Compression after Transradial Catheterization.


Despite all of the above, as it was mentioned at the beginning of this article, angioplasty was associated with more freedom from angina (49.5% versus 31.5%; odds ratio [OR]: 2.47; 95% confidence interval [CI]: 1.30 to 4.72; p = 0.006), although neither FFR nor iFR could predict this effect.

 

This is undoubtedly one of the most interesting studies ever published on ischemic heart disease and, despite its scarce 196 patients, it is certainly bound to start a debate.

 

Original title: Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Single-Vessel Coronary Artery Disease. Physiology-Stratified Analysis of ORBITA.

Reference: Al-Lamee R et al. Circulation. 2018 May 22. Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...